Mario Polywka Joins Orbit Discovery’s Board of Directors
Orbit Discovery, an Oxford, UK-based biotech company developing an industry-leading peptide discovery platform, are pleased to announce that Dr Mario Polywka has joined their board as a non-executive director.
September 3, 2019
by b3cnewswire
Recursion secures funds to support AI-based drug discovery
Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding round led by the Scottish Mortgage Investment Trust.
July 17, 2019
by pharmaceutical-technology
Bayer joins Sensyne Health consortium for accelerating new medicine discovery
Bayer joins Sensyne Health consortium for accelerating new medicine discovery.
May 10, 2019
by pharmatimes
Exscientia Launches New Subsidiary
Exscientia K.K will spearhead the company's pharmaceutical interests across Asia.
March 27, 2019
Enamine, Lundbeck Extend Drug Discovery Pact
Enamine will support Lundbeck’s in-house discovery chemistry competencies with three principal assets
March 27, 2019
by contractpharma
BASi Appoints Key Executive
Scott Daniels, PhD joins as senior vice president of DMPK, effective as of March 1, 2019
March 8, 2019
by contractpharma
Novo Nordisk Purchases Berkeley Lights Beacon Platform
Novo Nordisk has purchased Berkeley LightsBeacon Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery.
December 13, 2018
by contractpharma
InveniAI, Kyowa Hakko Kirin Partner for Drug Discovery
InveniAI Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML), has entered a collaboration agreement with Kyowa Hakko Kirin to use AI and ML for drug discovery.
December 12, 2018
by contractpharma
Avacta, LG Chem Announce Collaboration
Avacta Group and LG Chem Life Sciencesannounced a multi-target collaboration and development agreement. The agreement provides LG Chem with the exclusive rights to develop and commercialize, on a worldwide basis
December 12, 2018
by contractpharma
Immunocore, Genentech Expand Anti-Cancer Alliance
Immunocore Ltd., a T Cell Receptor (TCR) biotechnology company, has entered into a new partnership with Genentech, a member of the Roche Group, to expand an existing discovery
November 28, 2018
by contractpharma
Sygnature Discovery Establishes U.S. Ops
Sygnature Discovery, a drug discovery and preclinical services company, is expanding its operations with the opening of its first U.S. office in Harvard Square, Cambridge, MA.
November 28, 2018
by contractpharma
Piramal Unveils New cGMP Kilo Lab Suite for APIs
Piramal Pharma Solutions (PPS) has completed its new cGMP kilo lab suite at its active pharmaceutical ingredient (API) site in Ennore, Chennai, India. The suite will formally open on...
November 27, 2018
by contractpharma